Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,368,735 papers from all fields of science
Search
Sign In
Create Free Account
norelgestromin
Known as:
17-deacetylnorgestimate
, norelgestromin [Chemical/Ingredient]
, Norplant 3-oxime
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Amenorrhea
Drug Allergy
Ethinyl Estradiol / norelgestromin
Liver diseases
Expand
Broader (5)
Combined Oral Contraceptives
Norgestrel
Norplant
Oximes
Expand
Narrower (2)
Ortho Evra
Xulane
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: A double-blind, randomized, bioequivalence and adhesion study in healthy women.
D. Parasrampuria
,
Subusola Vaughan
,
+5 authors
S. Fonseca
Contraception
2020
Corpus ID: 210826664
2015
2015
A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
Maria Gruber
,
Schmidt.M
,
+9 authors
Serrani
Contraception
2015
Corpus ID: 10665852
2010
2010
Iontophoretic Transdermal Drug Delivery
Longsheng Hu
,
P. Batheja
,
V. Meidan
,
B. Michniak-Kohn
2010
Corpus ID: 57408184
2004
2004
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells
S. Prifti
,
I. Lelle
,
T. Strowitzki
,
T. Rabe
Gynecological Endocrinology
2004
Corpus ID: 13657925
The function and clinical significance of the androgen receptor (AR) in human breast cancer are still not clear. The synthetic…
Expand
Review
2004
Review
2004
New Product Review (September 2003) Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra®)
Journal of family planning and reproductive…
2004
Corpus ID: 612605
This new transdermal contraceptive system (contraceptive patch), Evra® (Janssen-Cilag), received a UK product licence in 2003. In…
Expand
2003
2003
Transdermal Ethinylestradiol/Norelgestromin
K. Goa
,
G. Warner
,
S. Easthope
2003
Corpus ID: 68166901
En]SummaryAbstractEthinylestradiol 20 μg/day plus norelgestromin 150 μg/day have been formulated into a transdermal patch for…
Expand
Review
2003
Review
2003
Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
K. Goa
,
G. Warner
,
S. Easthope
Treatments in Endocrinology
2003
Corpus ID: 23814949
UNLABELLED Ethinylestradiol 20 microg/day plus norelgestromin 150 microg/day have been formulated into a transdermal patch for…
Expand
2001
2001
Pharmacokinetics of Norelgestromin and Ethinyl Estradiol from Two Consecutive Contraceptive Patches
L. Abrams
,
Ms. Donna M. Skee
,
F. Wong
,
MS Anderson
,
P. Leese
Journal of clinical pharmacology
2001
Corpus ID: 27598775
The primary objective of this open‐label study was to determine the pharmacokinetics of norelgestromin (NGMN) and ethinyl…
Expand
Review
2001
Review
2001
Norgestimate. From the laboratory to three clinical indications.
M. Henzl
Journal of reproductive medicine
2001
Corpus ID: 22036703
This review of preclinical studies and clinical trials of efficacy and safety examines the relation between structure and…
Expand
1999
1999
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
F. Wong
,
R. Edom
,
+4 authors
G. Tegegne
Journal of Chromatography B: Biomedical Sciences…
1999
Corpus ID: 30064267
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE